[Form 4] DocuSign, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Irving Blake, a director of DocuSign, Inc. (DOCU), reported purchases and a grant on Form 4. On 08/29/2025 Mr. Blake acquired 729 shares of common stock at no cash price (Transaction Code M), bringing his total direct beneficial ownership to 23,906 shares. He also received a grant of 729 Restricted Stock Units (RSUs) that vest quarterly over one year beginning May 29, 2025, with the final installment accelerated to the earlier of the next annual meeting or the one-year anniversary. The RSUs do not expire and convert one-for-one into common shares upon vesting. The filing was signed by an attorney-in-fact on 09/02/2025.

Positive

• Director alignment: Grant of 729 RSUs ties the director's compensation to shareholder value through time-based vesting.
• Increased direct stake: Acquisition raises direct beneficial ownership to 23,906 shares, showing insider participation.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director increased direct stake modestly and received time-based RSUs that align incentives with shareholders.

The reported acquisition of 729 shares at $0 and the grant of 729 RSUs modestly raises the director's direct and contingent ownership. The filing shows 23,906 total shares beneficially owned after the transaction and 2,187 RSUs reported as beneficially owned following the grant. The RSU schedule vests quarterly over one year with an acceleration clause tied to the next annual meeting, which is typical for director compensation and limits dilution timing risk. For investors, this is a routine insider alignment event rather than a material corporate action.

Corporate Governance Expert

TL;DR: Compensation appears standard for a director: time-based RSUs with one-year vesting and an acceleration cap.

The grant's structure—vesting commencement 05/29/2025, quarterly vesting over one year, and acceleration to the next annual meeting—reflects standard governance practice to retain and align non-employee directors. The RSUs' non-expiration clause clarifies they either vest or are canceled, removing long-dated overhang. Reporting under Section 16 was timely and executed via attorney-in-fact. There are no disclosed related-party or unusual terms in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Irving Blake

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		M		729	A	$0	23,906	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/29/2025		M			729	(2)	(3)	Common Stock	729	$0	2,187	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.

3. The RSUs do not expire; they either vest or are canceled prior to vesting date.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DocuSign director Irving Blake report on Form 4 (DOCU)?

He reported acquiring 729 common shares at $0 on 08/29/2025 and receiving a grant of 729 RSUs with quarterly vesting.

How many shares does Irving Blake beneficially own after the transaction?

The filing shows total direct beneficial ownership of 23,906 shares following the reported transaction.

What are the vesting terms for the RSUs granted to Irving Blake?

RSUs commence vesting on 05/29/2025 and vest in equal quarterly installments over one year, with the fourth installment accelerated to the earlier of the next annual meeting or the one-year anniversary.

Do the RSUs expire if unvested?

No; the filing states the RSUs do not expire and will either vest or be canceled prior to vesting.

When was the Form 4 signed and filed?

The signature by attorney-in-fact is dated 09/02/2025, and the earliest transaction date is 08/29/2025.